AMISULPRIDE SCP amisulpride 50 mg uncoated tablet blister pack

Pajjiż: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

amisulpride, Quantity: 50 mg

Disponibbli minn:

Southern Cross Pharma Pty Ltd

INN (Isem Internazzjonali):

Amisulpride

Għamla farmaċewtika:

Tablet, uncoated

Kompożizzjoni:

Excipient Ingredients: sodium starch glycollate type A; lactose monohydrate; microcrystalline cellulose; magnesium stearate; hypromellose

Rotta amministrattiva:

Oral

Unitajiet fil-pakkett:

90, 30, 60

Tip ta 'preskrizzjoni:

(S4) Prescription Only Medicine

Indikazzjonijiet terapewtiċi:

Amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.

Sommarju tal-prodott:

Visual Identification: White round flat tablets with diameter 7mm; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

L-istatus ta 'awtorizzazzjoni:

Licence status A

Data ta 'l-awtorizzazzjoni:

2016-01-29